• 1

    Dangsvang S, 1981. Gnathostomiasis in southeast Asia. Southeast Asian J Trop Med Public Health 12 :319–332.

  • 2

    Nawa Y, 1991. Historical review and current status of gnathostomiasis in Asia. Southeast Asian J Trop Med Public Health 22 :217–219.

  • 3

    Faust EC, Beaver PC, Jung RC, 1975. Animal Agents and Vectors of Human Diseases. Fourth edition. Philadelphia: Lea & Febiger, 272.

  • 4

    Daengsvang S, Pecharanond K, Phrukoudom, Youngyi P, 1967. Gnathostomiasis in Thailand. Annual Progress Report San Francisco: SEATO Medical Research Laboratory Clinical Research Center, 251–271.

  • 5

    Sirisumpan P, 1962. A survey of intestinal helminths in stray dogs in Bangkok and Phonburi. J Med Assoc Thai 45 :567–577.

  • 6

    Promas C, Daengsvang S, 1933. Preliminary report of a study on the life cycle of Gnathostoma spinigerum. J Parasitol 19 :11–17.

  • 7

    Boongird P, Phanpradit P, Siridej N, Chirachariyavej T, Chuajirun S, Vejjajiva A, 1977. Neurological manifestation of gnathostomiasis. J Neurol Sci 31 :279–291.

    • Search Google Scholar
    • Export Citation
  • 8

    Rusnak JM, Lucey DR, 1993. Clinical gnathostomiasis: case report and review of the English language literature. Clin Infect Dis 16 :33–50.

    • Search Google Scholar
    • Export Citation
  • 9

    Ratanarpee S, Jesadapalarakul S, 1982. A case of gnathostomiasis simulating acute appendicitis. J Med Assoc Thai 65 :443–447.

  • 10

    Thansuphasiri P, 1974. Corneal perforation by Gnathostoma spinigerum. Siriraj Hosp Gaz 26 :2211–2218.

  • 11

    Jaroonvesamu N, Harinasuta T, 1973. Comparison of quinine with prednisolone in treatment of gnathostomiasis. J Med Assoc Thai 56 :312–313.

    • Search Google Scholar
    • Export Citation
  • 12

    Daengsvang S, Sermswatsri B, Youngyi P, Guhame D, 1971. A preliminary study of chemotherapy of Gnathostoma spinigerum infections in cats with ancylol disophenol (2,6-diiodo-4-nitrophenol). Southeast Asian J Trop Med Public Health 2 :359–361.

    • Search Google Scholar
    • Export Citation
  • 13

    Oshima T, Fujita K, 1977. A case of gnathostomiasis in Yokohama and its treatment by thiabendazole. Jpn J Parasitol 26 :7.

  • 14

    Yingyord P, Daengsvang S, 1983. Experimental treatment of Gnathostoma spinigerum infection in mice with thiabendazole. Southeast Asian J Trop Med Public Health 14 :560–561.

    • Search Google Scholar
    • Export Citation
  • 15

    Kraivichian P, Kulkumthorn M, Yingyourd P, Akarabovorn P, Paireepai CC, 1992. Albendazole for the treatment of human gnathostomiasis. Trans R Soc Trop Med Hyg 86 :418–421.

    • Search Google Scholar
    • Export Citation
  • 16

    Inkatanuvat S, Suntharasamai P, Vutikus S, Rigunti M, 1998. Change of liver function after albendazole treatment in human gnathostomiasis. J Med Assoc Thai 81 :735–739.

    • Search Google Scholar
    • Export Citation
  • 17

    Silva N, Guyatt H, Bundy D, 1997. Anthelmintics a comparative review of their clinical Pharmacology. Drugs 53 :769–788.

  • 18

    Campbell WC, 1983. Ivermectin: a potent new antiparasite agent. Science 25 :823–828.

  • 19

    Campbell WC, 1985. Ivermectin: an update. Parasitol Today 1 :10–16.

  • 20

    Greene BM, Brown KR, Taylor HR, 1989. Use of ivermectin in humans. Campbell WC, ed. Ivermectin and Abamectin. New York: Springer-Verlag, 311–323.

  • 21

    Greene BM, Taylor HR, Cupp EW, Murphy RP, White AT, Aziz MA, Schulz-Key H, D’Anna SA, Newland HS, Goldschmidt LP, 1985. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med 313 :133–138.

    • Search Google Scholar
    • Export Citation
  • 22

    Encarnacion CF, Giordano MF, Murray HW, 1994. Onchocerciasis in New York City: the Moa-Manhattan connection. Arch Intern Med 154 :1749–1751.

    • Search Google Scholar
    • Export Citation
  • 23

    Goa KL, Mctavish D, Clissold LP, 1991. Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 42 :640–652.

    • Search Google Scholar
    • Export Citation
  • 24

    Caumes E, Carriere J, Datry A, Gaxotte P, Danis M, Gentilini M, 1993. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrants. Am J Trop MedHyg 49 :641–644.

    • Search Google Scholar
    • Export Citation
  • 25

    Waikagul J, Thairungroj M, Visrassuk A, Visiassuk K, 1994. A preliminary study on the efficacy of mebendazole, thiabendazole, praziquantel and ivermectin against gnathostomiasis in rats. Ann Trop Med Parasitol 17 :76–81.

    • Search Google Scholar
    • Export Citation
  • 26

    Anantaphruti MT, Nuamtanong S, Waikagul J, 1992. Effect of ivermectin on experimental gnathostomiasis in rabbits. Trop Med Parasitol 43 :56–57.

    • Search Google Scholar
    • Export Citation
  • 27

    Laemmli UK, Favre M, 1973. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol 80 :575–599.

  • 28

    Tapchisri P, Nopparatana C, Chaicumpa W, Setasuban P, 1991. Specific antigen of Gnathostoma spinigerum for immunodiagnosis of human gnathostomiasis. Int J Parasitol 21 :315–319.

    • Search Google Scholar
    • Export Citation
  • 29

    Chanthachume N, Kulkumthorn M, Jongwutiwes S, 1988. Evaluation of skin test for human gnathostomiasis. Chula Med J 32 :243–248.

  • 30

    Fredberg IM, Eisen AZ, Austen KF, Kate SI, Fizpatrick TB, 1999. Fitzpatrick’s Dermatology in General Medicine. Fifth edition. New York: McGraw-Hill, 1411.

  • 31

    Triteeraprapap S, Thamapanyawat B, Nuchprayoon I, Thanamun B, 2000. Eosinophilia with low prevalence of parasitism in a rural area of Maha Sarakham Province after annual mass treatment with mebendazole and albendazole. Chula Med J 44 :423–431.

    • Search Google Scholar
    • Export Citation
  • 32

    Nuchprayoon S, Sanprasert V, Suntravat M, Kraivichian K, Saksirisampant V, Nuchprayoon I, 2003. Study of specific IgG subclass antibodies for diagnosis of Gnathostoma spinigerum. Parasitol Res 91 :137–143.

    • Search Google Scholar
    • Export Citation
  • 33

    Nopparatana C, Setasuban P, Chaicumpa W, Tapchaisri P, 1991. Purification of Gnathostoma spinigerum specific antigen and immunology of human gnathostomiasis. Int J Parasitol 21 :677–687.

    • Search Google Scholar
    • Export Citation
  • 34

    Daengsvang S, Sermswatsri B, Youngyi P, Guhame D, 1970. Penetration of the skin by Gnathostoma spinigerum larvae. Ann Trop Med Parasitol 64 :399–402.

    • Search Google Scholar
    • Export Citation
  • 35

    Daengsvang S, 1949. Human gnathostomiasis in Siam with reference to the method of prevention. J Parasitol 35 :116–121.

  • 36

    Ogata K, Nava Y, Akahane H, Diaz Camacho SP, Lamothe-Argumedo R, Cruz-Reyes A, 1998. Short report: gnathostomiasis in Mexico. Am J Trop Med Hyg 58 :316–318.

    • Search Google Scholar
    • Export Citation
  • 37

    Yingyourd P, Sitthichareonchai P, Siriranon N, 1988. Study on eosinophilia in mice administered with Gnathostoma spinigerum larvae. Chula Med J 32 :257–265.

    • Search Google Scholar
    • Export Citation
  • 38

    Suntharasamai P, Riganti M, Chittamas S, Desakorn V, 1992. Albendazole stimulates outward migration of Gnathostoma spinigerum to the dermis in man. Southeast Asian J Trop Med Public Health 23 :16–722.

    • Search Google Scholar
    • Export Citation
  • 39

    Nontasut P, Bussaratid V, Chullawichit S, Charoensook N, Visetsuk K, 2000. Comparison of ivermectin and albendazole treatment for gnathostomiasis. Southeast Asian J Trop Med Public Health 31 :374–377.

    • Search Google Scholar
    • Export Citation

 

 

 

 

TREATMENT OF CUTANEOUS GNATHOSTOMIASIS WITH IVERMECTIN

View More View Less
  • 1 Department of Parasitology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Faculty of Allied Health Science, Thammasart University, Pathumthani, Thailand

In a randomized open study, we compared the efficacy of a single dose of oral ivermectin (200 μg/kg) and oral albendazole (400 mg/day for 21 days) for the treatment of cutaneous gnathostomiasis. Thirty-one patients were randomly assigned to receive ivermectin (n = 17) or albendazole (n = 14). Thirteen of 17 patients who received ivermectin responded, 3 relapsed, and 1 was unresponsive (cure rate = 76%). Thirteen of 14 patients who received albendazole responded very well and did not relapse. Only one patient was unresponsive (cure rate = 92%; P > 0.05). No major side effects were observed in both groups. We concluded that a single dose of ivermectin (200 μg/kg) is less effective than albendazole (400 mg/day for 21 days) for treatment of cutaneous gnathostomiasis, but there was no statistically significant difference (P > 0.05).

Save